Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1998
12/09/1998EP0881886A1 Animal feed
12/09/1998EP0881881A1 Antiparasitic composition for treating and protecting pets
12/09/1998EP0771188B1 Soap composition
12/09/1998EP0716605B1 Blocking the accumulation of germs on human cells
12/09/1998EP0463073B1 IMMUNOGLOBULIN A1 PROTEASES (IgA1 PROTEASES), METHOD OF GENE-TECHNOLOGICALLY PRODUCING THIS TYPE OF ENZYME AND VACCINES CONTAINING THE ENZYMES AND FRAGMENTS THEREOF FOR IMMUNIZING AGAINST BACTERIAL MENINGITIS AND OTHER DISEASES CAUSED BY IgA1 PROTEASE-PRODUCING BACTERIA
12/09/1998CN1201463A Novel nucleoside derivatives and process for preparing same
12/09/1998CN1201459A Novel pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising same as active ingredient
12/09/1998CN1201395A Method for treatment of helicobacter pylori infections
12/09/1998CN1201384A Aerosol compositions
12/09/1998CN1201369A Stimulation of cell-mediated immune responses by targeted particulated genetic immunization
12/09/1998CN1200942A Interferon liposome jellies
12/09/1998CN1200941A Venereal disease preventing medicine containing interferon
12/09/1998CN1200928A Sugar-less particles for treating infant's cold and preparation method therefor
12/09/1998CN1200927A Method for extracting earthworm element from Jpan Dula earthworm
12/08/1998US5847164 Method for the preparation of chromanone 7
12/08/1998US5847127 Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives
12/08/1998US5847119 2-bromo-and derivatives of 3-bromo-and 3,3-dibromo-4-oxo-azetidines, processes for the preparation thereof and use thereof
12/08/1998US5847112 Process for making capsular polysaccharides from Streptococcus pneumoniae
12/08/1998US5847106 Monomeric and dimeric nucleosides with silyl-containing diamino phosphorous linkages
12/08/1998US5847092 Erythromycin A 9-0 oxime derivatives endowed with antibiotic activity
12/08/1998US5847081 Conjugate vaccine for group B Streptococcus
12/08/1998US5847077 Fungal multisubunit protein complex critical for expression of fungal proteins
12/08/1998US5847004 Method for in vivo reduction of nitric oxide levels and compositions useful therefor
12/08/1998US5846987 Retroviral protease inhibiting compounds
12/08/1998US5846957 Use of an ester of inositoltrisphosphate for the preparing of medicaments
12/08/1998US5846948 Herpes simplex virus ORF P is a repressor of viral protein synthesis
12/08/1998US5846947 Composition containing nucleic acids, preparation and uses
12/08/1998US5846946 Compositions and methods for administering Borrelia DNA
12/08/1998US5846943 Solid support matricles containing a toxin binding oligosaccharide
12/08/1998US5846827 Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of CTL
12/08/1998US5846825 Feline derived T-cell lines for producing FIV
12/08/1998US5846806 Identification of a human cytomegalovirus gene region involved in down-regulation of MHC class I heavy chain expression
12/08/1998US5846805 Culture of swine infertility and respiratory syndrome virus in simian cells
12/08/1998US5846733 Structural phosphoprotein (PP150) of human cytomegalovirus, and the preparation and use thereof
12/08/1998US5846712 Tumor suppressor gene, HIC-1
12/08/1998US5846707 Herpes simplex virus as a vector
12/08/1998US5846547 Streptococcal C5a peptidase vaccine
12/08/1998US5846546 Preparation and use of viral vectors for mixed envelope protein immunogenic composition against human immunodeficiency viruses
12/08/1998US5846545 Targeted delivery of cyclopropylbenzindole-containing cytotoxic drugs
12/08/1998US5846540 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
12/08/1998CA2055598C Feline calicivirus gene
12/08/1998CA2002106C O-acylated derivatives of 1,5-dideoxy-1, 5-imino-d-glucitol
12/05/1998CA2233591A1 Novel compounds
12/04/1998CA2233590A1 Novel compounds
12/04/1998CA2233587A1 Novel compounds
12/03/1998WO1998054366A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
12/03/1998WO1998054296A1 Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin
12/03/1998WO1998054279A1 Disinfecting compositions and processes for disinfecting surfaces
12/03/1998WO1998054226A1 Processes for production of immunoglobulin a in milk
12/03/1998WO1998054225A2 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes
12/03/1998WO1998054197A1 Multicyclic erythromycin derivatives
12/03/1998WO1998054190A1 Novel compounds
12/03/1998WO1998054185A1 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-ones
12/03/1998WO1998054178A1 Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability
12/03/1998WO1998054170A1 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND 1-OXOISOINDOLINES AND METHOD OF REDUCING TNFα LEVELS
12/03/1998WO1998054169A1 Substituted cyclobutylamine derivatives
12/03/1998WO1998054161A1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
12/03/1998WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA
12/03/1998WO1998053821A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-β1
12/03/1998WO1998053801A1 Conjugated peptide nucleic acids having enhanced cellular uptake
12/03/1998WO1998045712A3 20 human secreted proteins
12/03/1998DE19722888A1 Human-CD28 spezifische monoklonale Antikörper zur antigenunspezifischen Aktivierung von T-Lymphozyten Human CD28 specific monoclonal antibodies for the antigen non-specific activation of T-lymphocytes
12/03/1998CA2293703A1 Disinfecting compositions and processes for disinfecting surfaces
12/03/1998CA2292580A1 Substituted cyclobutylamine derivative
12/03/1998CA2291881A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
12/03/1998CA2291839A1 Conjugated peptide nucleic acids having enhanced cellular uptake
12/03/1998CA2291487A1 Processes for production of immunoglobulin a in milk
12/03/1998CA2291086A1 Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability
12/03/1998CA2288750A1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
12/03/1998CA2288317A1 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo¬3,2-d|pyrimidin-4-ones
12/02/1998EP0881297A2 Histidine kinase
12/02/1998EP0881296A2 Histidine kinase
12/02/1998EP0881295A2 Histidine kinase
12/02/1998EP0881292A2 Streptocococcus pneumoniae peptide release factor
12/02/1998EP0881289A2 Novel 7TM receptor (H2CAA71)
12/02/1998EP0881286A2 Histidine kinase
12/02/1998EP0881285A1 D-Alanine transferase
12/02/1998EP0881231A2 HCV peptide-antigens and a method of testing for the hepatitis C virus
12/02/1998EP0881230A2 Urea and thiourea derivatives of antibiotic glycopeptides
12/02/1998EP0881229A2 Alkylated antibiotic hexapeptides
12/02/1998EP0880894A1 Selective bactericide against food-borne pathogenic bacteria
12/02/1998EP0880541A1 Derivatives of antibiotic ge2270 factors
12/02/1998EP0880533A1 Triazole derivatives useful in therapy
12/02/1998EP0880527A1 PYRIDO(3,2,1-ij)-1,3,4-BENZOXADIAZINE DERIVATIVE
12/02/1998EP0880501A1 Heterocyclic compounds useful as pharmaceutical agents
12/02/1998EP0880499A1 Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
12/02/1998EP0880364A2 Contraceptive release systems with antibacterial and/or antiviral effect
12/02/1998EP0880362A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist
12/02/1998EP0880360A1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
12/02/1998EP0880351A1 Polymeric quaternary ammonium compounds and their use as ophthalmic antimicrobials
12/02/1998EP0746564B1 4-n-substituted sialic acids and their sialosides
12/02/1998EP0666743B1 Soluble calcium lactate/quindonecarboxylic acids complexes as non-irritating parenteral forms
12/02/1998EP0583358B1 Partial liquid breathing of fluorocarbons
12/02/1998EP0545991B1 Peptides that block human immunodeficiency virus infections and methods of use thereof
12/02/1998EP0527785B1 Improvements relating to the detection of viruses
12/02/1998CN1200672A Pharmaceutical formulation
12/02/1998CN1040984C Liponucleotide of seco-nucleosides, process for preparing same and pharmaceutical composition with anti-viral action contg. same
12/02/1998CN1040980C Second messenger cell signaling inhibitors
12/02/1998CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene
12/01/1998US5844106 Modified oligonucleotides, their preparation and their use
1 ... 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 ... 1798